Hostname: page-component-7c8c6479df-hgkh8 Total loading time: 0 Render date: 2024-03-28T14:04:10.726Z Has data issue: false hasContentIssue false

Time-course study of high-dose creatine supplementation for endogenous creatine synthesis

Published online by Cambridge University Press:  12 May 2008

M. Xiang
Affiliation:
Centre for Biosciences Research, School of Science, University of Greenwich, Kent ME4 4TB, UK
L. S. Harbige
Affiliation:
Centre for Biosciences Research, School of Science, University of Greenwich, Kent ME4 4TB, UK Medway School of Pharmacy, University of Kent and University of Greenwich, Kent ME4 4TB, UK
X. Li
Affiliation:
Division of Nutrition and Biochemistry, Institute of Sports Medicine, The Third Hospital, Peking University, Beijing, People's Republic of China
B. Li
Affiliation:
Division of Nutrition and Biochemistry, Institute of Sports Medicine, The Third Hospital, Peking University, Beijing, People's Republic of China
H. Ai
Affiliation:
Division of Nutrition and Biochemistry, Institute of Sports Medicine, The Third Hospital, Peking University, Beijing, People's Republic of China
Rights & Permissions [Opens in a new window]

Abstract

Type
1st International Immunonutrition Workshop, Valencia, 3–5 October 2007, Valencia, Spain
Copyright
Copyright © The Authors 2008

Creatine (Cre) is a popular nutritional supplement in many population groups, and has potential therapeutic effects in some diseases(Reference Prass, Royl, Lindauer, Freyer, Megow, Dirnagl, Stockler-Ipsiroglu, Wallimann and Priller1Reference Bender, Auer and Merl4). Cre supplementation may increase the Cre content of muscle(Reference Rockwell, Rankin and Toderico5), and improve muscle strength(Reference Becque, Lochmann and Melrose6). l-Arginine:glycine amidinotransferase (L-AGAT) in the kidney is the rate-limiting enzyme of endogenous Cre synthesis in mammals, and guanidinoacetic acid (GAA) is the precursor in this synthesis. The aim of the present study was to determine the effect of high-dose Cre supplementation on L-AGAT activity and endogenous Cre synthesis. A time-course of repression of L-AGAT activity and GAA concentration by 3.0 g supplemented Cre /kg per d was studied in adult male Sprague-Dawley rats. In the comparison between groups supplemented with 3.0 g Cre/kg body weight per d for 0.5, 1, 2, 4 and 8 d respectively and the control group (without Cre supplementation; n 10), the L-AGAT activity in the kidney in the supplemented groups decreased (%) by 31.7, 41.4, 48.9, 61.4 and 73.5 respectively (Fig. 1(A)). Furthermore, the kidney concentration of GAA for the groups receiving 3.0 g Cre/kg per d for 0.5, 1, 2, 4 and 8 d decreased (%) by 4.9, 20.4, 31.7, 37.9 and 40.8 respectively (Fig. 1(B)). The total Cre in gastrocnemius muscle increased gradually with time and was 109.3% above the control levels after 8 d. In the groups receiving 3.0 g Cre/kg per d for 0.5, 1 and 2 d the serum creatinine increased significantly and, then declined gradually until day 8. No significant differences were found in the serum creatine kinase activity among the six groups.

These results indicate that for rats L-AGAT activity and GAA concentration could be repressed rapidly by 3.0 g Cre/kg per d in 8 d, suggesting that high-dose Cre supplementation may quickly result in the depression of endogenous Cre metabolism. These results may be relevant to the immune system and this aspect is currently being investigated in lymphocytes, as little is known about the effect of Cre supplementation on immune cells.

References

1. Prass, K, Royl, G, Lindauer, U, Freyer, D, Megow, D, Dirnagl, U, Stockler-Ipsiroglu, G, Wallimann, T & Priller, J (2007) J Cereb Blood Flow Metab 27, 452459.CrossRefGoogle Scholar
2. Kley, RA, Vorgerd, M & Tarnopolsky, MA (2007) Cochrane Database Syst Rev 1, CD004760.Google Scholar
3. McMorris, T, Harris, RC, Swain, J, Corbett, J, Collard, K, Dyson, RJ, Dye, L, Hodgson, C & Draper, N (2006) Psychopharmacology (Berl) 17, 111.Google Scholar
4. Bender, A, Auer, DP, Merl, T et al. (2005) J Neurol 252, 3641.CrossRefGoogle Scholar
5. Rockwell, JA, Rankin, JW & Toderico, B (2001) Med Sci Sports Exerc 33, 6168.CrossRefGoogle Scholar
6. Becque, MD, Lochmann, JD & Melrose, DR (2000) Med Sci Sports Exerc 32, 654658.CrossRefGoogle Scholar